J&J, Novavax COVID Vaccines Work Well, But Weaken Against a New Variant
FRIDAY, Jan. 29, 2021 (HealthDay News) — Two widely anticipated new COVID-19 vaccines — from Johnson & Johnson and Novavax — appear to halt infections in places where more contagious variants are circulating, new trials show. But there was one key exception: Each loses a significant amount of its protectiveContinue Reading